A new drug combination with the potential to extend patient survival in lung transplant recipients has been identified. Sirolimus plus Tacrolimus combination helps in the long-term prevention of chronic rejection. Further studies would be required to investigate optimal dosages of the drugs to treat the patients.from Medindia Latest Updates https://ift.tt/2zMKgbR
No comments:
Post a Comment